PomDoctor(POM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

POM PomDoctor

Market Closed 03-13 16:00:00 EDT

0.3961

+0.0128

+3.34%

盘后0.4099

+0.0138+3.48%

19:37 EDT

High0.4200	Low0.3600	Vol2.91M
Open0.3800	D1 Closing0.3833	Amplitude15.65%
Mkt Cap46.92M	Tradable Cap1.98M	Total Shares118.44M
T/O1.17M	T/O Rate58.24%	Tradable Shares5.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"POM","market":"US","secType":"STK","nameCN":"PomDoctor","latestPrice":0.3961,"timestamp":1773432000000,"preClose":0.3833,"halted":0,"volume":2911998,"hourTrading":{"tag":"盘后","latestPrice":0.4099,"preClose":0.3961,"latestTime":"19:37 EDT","volume":4497,"amount":1839.428,"timestamp":1773445055130,"change":0.0138,"changeRate":0.03484,"amplitude":0.059581},"delay":0,"changeRate":0.033394208192016786,"floatShares":5000004,"shares":118444560,"eps":-0.549017,"marketStatus":"Market Closed","change":0.0128,"latestTime":"03-13 16:00:00 EDT","open":0.38,"high":0.42,"low":0.36,"amount":1174253.8751064,"amplitude":0.156535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.549017,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"listingDate":1759896000000,"exchange":"NASDAQ","adjPreClose":0.3833,"preHourTrading":{"tag":"盘前","latestPrice":0.388,"preClose":0.3833,"latestTime":"09:29 EDT","volume":20012,"amount":7719.2627804,"timestamp":1773408599126,"change":0.0047,"changeRate":0.012262,"amplitude":0.041482},"postHourTrading":{"tag":"盘后","latestPrice":0.4099,"preClose":0.3961,"latestTime":"19:37 EDT","volume":4497,"amount":1839.428,"timestamp":1773445055130,"change":0.0138,"changeRate":0.03484,"amplitude":0.059581},"volumeRatio":1.2705014304165856},"requestUrl":"/m/hq/s/POM/tweets","defaultTab":"tweets","newsList":[{"id":"2619194908","title":"Pomdoctor Ltd. Plans R&D and Deployment of AI-Powered Medical-Grade Wearables to Build a Closed-Loop, Full-Cycle Chronic Disease Management Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194908?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:00","pubTimestamp":1773403224,"startTime":"0","endTime":"0","summary":"Pomdoctor Ltd. Plans R&D and Deployment of AI-Powered Medical-Grade Wearables to Build a Closed-Loop, Full-Cycle Chronic Disease Management Ecosystem. Pomdoctor Ltd. announced plans to upgrade its strategy around AI and medical-grade smart wearables to support full-cycle chronic disease management. The company said it will accelerate R&D and scenario-based deployment to build a closed-loop ecosystem integrating devices, data, algorithms and services. Planned actions include developing medical-grade wearable devices for continuous physiological monitoring, building an AI-powered management system based on clinical guidelines to support risk monitoring and doctor-patient collaboration, and integrating these tools with its internet hospital platform, pharmaceutical supply chain and chronic disease service infrastructure to deliver monitoring, early warning, intervention and follow-up services. Pomdoctor said it intends to carry out R&D and commercialization in compliance with applicable m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL1LSH6x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"gpt_icon":0},{"id":"2619619499","title":"Pomdoctor Limited Announces Strategic Upgrade, Focusing on \"AI + Medical-Grade Smart Wearables\" to Build a New Ecosystem for Full-Cycle Chronic Disease Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2619619499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619619499?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:00","pubTimestamp":1773403202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nTUA4ZDC36:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["POM","BK4175"],"gpt_icon":0},{"id":"2619153696","title":"Class action lawsuit targets PomDoctor over alleged securities fraud between Oct. 9 and Dec. 11, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2619153696","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619153696?lang=en_us&edition=fundamental","pubTime":"2026-03-13 00:01","pubTimestamp":1773331289,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against PomDoctor and certain officers, alleging violations of U.S. federal securities laws. The suit seeks damages for investors who bought or acquired PomDoctor securities between Oct. 9, 2025 and Dec. 11, 2025. The complaint alleges PomDoctor was tied to a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals. It also alleges insiders or affiliates used offshore or nominee accounts to coordinate share sales during a period of alleged price inflation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL5ZZmTm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BKPKM429.USD","LU2210149790.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","POM","SG9999014013.SGD","BK4175","IE00B3QW5Z07.USD","BK4585","SG9999014021.USD","LU2210150020.SGD","SG9999014039.USD"],"gpt_icon":0},{"id":"2618728056","title":"ADRs Advance; PomDoctor Ltd. Climbs 74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618728056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618728056?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:30","pubTimestamp":1773088200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Monday, as the S&P/BNY Mellon index of American depositary receipts gained 1.6% to 247.88.The European index increased 1.3% to 219.82. The Asian index added 1.8% to 325.53. The Latin American index rose 2.1% to 273.04, while the emerging-markets index increased 2.2% to 553.19.China's PomDoctor Ltd. was the biggest leader during the session, soaring 74% to 44 cents, and China-based XChange TEC.INC soared 35% to $1.05. Turbo Energy S.A., which is based in Spain, rounded out the top three leaders on Monday, with shares soaring 34% to $5.05.Huize Holding Ltd., based in China, posted the largest decline, plunging 14% to $1.63, followed by shares of China's Jinxin Technology Holding Co., which tumbled 13% to 42 cents. Shares of Hong Kong-based Yunji Inc. tumbled 12% to $1.55.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"gpt_icon":0},{"id":"2616379186","title":"Rosen Law Firm Flags April 7 Lead Plaintiff Deadline in PomDoctor Securities Class Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2616379186","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616379186?lang=en_us&edition=fundamental","pubTime":"2026-03-04 04:23","pubTimestamp":1772569400,"startTime":"0","endTime":"0","summary":"A securities class action has been filed against PomDoctor Ltd. on behalf of investors who bought shares between Oct. 9, 2025 and Dec. 11, 2025. The suit alleges the company made misleading statements and omissions by failing to disclose an alleged stock promotion scheme, purported use of offshore or nominee accounts to dump shares during an inflation campaign, and artificial trading and rumors affecting the stock price. An April 7, 2026 deadline has been set for investors seeking to be appointed lead plaintiff.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL1QbPhp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BGHQF748.EUR","NDAQ","BK4112","LU2210150020.SGD","SG9999014005.SGD","LU2095319765.USD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","POM","SG9999014021.USD","SG9999014039.USD","IE00B64PRP62.GBP","BK4585","BK4588","BK4175"],"gpt_icon":0},{"id":"2616373784","title":"Class Action Lawsuit Targets PomDoctor Ltd. Over Alleged Securities Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=2616373784","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616373784?lang=en_us&edition=fundamental","pubTime":"2026-03-04 02:48","pubTimestamp":1772563719,"startTime":"0","endTime":"0","summary":"A class action lawsuit has been filed against PomDoctor Ltd. in connection with alleged securities fraud and other unlawful business practices. The suit focuses on claims that the company and certain officers or directors were involved in an illicit pump-and-dump promotion scheme that preceded a sharp rise in the stock to $6.09 and a subsequent plunge of about 91% to $0.50 on Dec. 10, 2025. Investors who bought PomDoctor securities during the class period have until April 6, 2026, to seek appointment as lead plaintiff.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL657Nxz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","NDAQ","POM","BK4112","SG9999014039.USD","SG9999014021.USD","BK4175","SG9999014005.SGD","BK4588","LU2210150020.SGD","SG9999014013.SGD","LU2095319765.USD","LU0314104364.USD","IE00B64PRP62.GBP","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2614553190","title":"Rosen Law Firm Urges PomDoctor Investors to Seek Counsel Ahead of April 7 Lead Plaintiff Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2614553190","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614553190?lang=en_us&edition=fundamental","pubTime":"2026-02-26 04:50","pubTimestamp":1772052654,"startTime":"0","endTime":"0","summary":"A securities class action has been filed against PomDoctor Ltd. on behalf of investors who bought shares between Oct. 9, 2025 and Dec. 11, 2025. The suit alleges the company made misleading statements and omissions tied to an alleged stock promotion scheme, including social media misinformation, insider or affiliate share dumping through offshore or nominee accounts, and inadequate disclosure of purported artificial trading activity. The deadline to seek appointment as lead plaintiff is April 7, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLc1FSz1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"gpt_icon":0},{"id":"2613994752","title":"Pomdoctor Investors Face April 13 Lead Plaintiff Deadline in Securities Class Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2613994752","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613994752?lang=en_us&edition=fundamental","pubTime":"2026-02-24 09:40","pubTimestamp":1771897200,"startTime":"0","endTime":"0","summary":"Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Ltd. and has reminded investors of an April 13, 2026 deadline to seek lead-plaintiff status in a federal securities class action. The lawsuit alleges the company and certain executives made misleading statements and omissions tied to an alleged stock promotion scheme, artificial trading activity, and coordinated share dumping, and follows a sharp share-price drop in December 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL2w2MvN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"gpt_icon":0},{"id":"2613427407","title":"Rosen Law Firm Alerts PomDoctor Investors to April 7 Lead Plaintiff Deadline in Securities Class Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2613427407","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613427407?lang=en_us&edition=fundamental","pubTime":"2026-02-23 07:22","pubTimestamp":1771802521,"startTime":"0","endTime":"0","summary":"Rosen Law Firm is urging investors who bought PomDoctor Ltd. securities between Oct. 9, 2025 and Dec. 11, 2025 to seek counsel ahead of an April 7, 2026 deadline to request appointment as lead plaintiff in a securities class action. The lawsuit alleges the company and others made misleading statements and omissions tied to an alleged fraudulent stock promotion campaign, including social media misinformation, impersonation of financial professionals, and coordinated share dumping through offshore or nominee accounts that allegedly inflated the stock price.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260222:nNDL47gYzd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"gpt_icon":0},{"id":"2612253267","title":"Rosen Law Firm Urges PomDoctor Investors to Act Before April 7 Lead Plaintiff Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2612253267","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612253267?lang=en_us&edition=fundamental","pubTime":"2026-02-20 11:26","pubTimestamp":1771557985,"startTime":"0","endTime":"0","summary":"Rosen Law Firm has urged investors who bought PomDoctor Ltd. securities between Oct. 9, 2025 and Dec. 11, 2025 to seek counsel ahead of an April 7, 2026 deadline to seek lead-plaintiff status in a pending securities class action. The lawsuit alleges the company and other defendants made misleading statements and omissions tied to an alleged stock promotion scheme, including social media misinformation, share dumping via offshore or nominee accounts, and inadequate disclosures about purported artificial trading activity that inflated the stock price.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL2N85Lv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BGHQF748.EUR","POM","BK4585","LU0314104364.USD","SG9999014005.SGD","SG9999014039.USD","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","LU2095319765.USD","SG9999014013.SGD","IE00BKPKM429.USD","BK4112","BK4175"],"gpt_icon":0},{"id":"2612478629","title":"Rosen Law Firm Urges PomDoctor Investors to Join Securities Class Action by April 7 Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2612478629","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612478629?lang=en_us&edition=fundamental","pubTime":"2026-02-19 08:19","pubTimestamp":1771460393,"startTime":"0","endTime":"0","summary":"Rosen Law Firm is urging investors in PomDoctor Ltd. to seek legal counsel ahead of an April 7, 2026 deadline to seek lead-plaintiff status in a securities class action. The lawsuit alleges the company and related parties made misleading statements and omissions tied to an alleged stock-promotion scheme, including social media misinformation, coordinated share sales through offshore or nominee accounts, and inadequate risk disclosures during the October 9 to December 11, 2025 class period.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL6vDRNk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"gpt_icon":0},{"id":"2612452451","title":"Pomdoctor Ltd. Faces Shareholder Class Action Over Alleged Stock Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=2612452451","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612452451?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:06","pubTimestamp":1771333600,"startTime":"0","endTime":"0","summary":"A shareholder class action lawsuit has been filed against Pomdoctor Ltd., alleging the company was involved in a fraudulent stock promotion scheme that included misinformation on social media and the use of offshore accounts to coordinate share dumping during a price inflation campaign. The lawsuit claims Pomdoctor failed to disclose these activities in its public statements and risk disclosures. Investors who purchased shares between October 9, 2025, and December 11, 2025, may be eligible to seek lead plaintiff status, with an application deadline of April 6, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL3szzWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BKPKM429.USD","LU2210149790.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","POM","SG9999014013.SGD","BK4175","IE00B3QW5Z07.USD","BK4585","SG9999014021.USD","LU2210150020.SGD","SG9999014039.USD"],"gpt_icon":0},{"id":"2608868155","title":"Pomdoctor Limited Announces Receipt of Nasdaq Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2608868155","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608868155?lang=en_us&edition=fundamental","pubTime":"2026-02-02 19:00","pubTimestamp":1770030001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA69FMCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["POM","BK4175"],"gpt_icon":0},{"id":"2603991801","title":"Press Release: POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991801","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603991801?lang=en_us&edition=fundamental","pubTime":"2026-01-16 22:00","pubTimestamp":1768572000,"startTime":"0","endTime":"0","summary":"GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED  , a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic collaboration with leading domestic pharmaceutical companies to accelerate the growth of its internet hospital business. The Company expects these partnerships to become a core component of its long-term strategy to expand online hospital operations and enhance overall profitability.Mr. Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor, commented, \"China's rapidly expanding online pharmaceutical sales market offers significant development opportunities not only for pharmaceutical manufacturers seeking scalable and efficient distribution channels, but also for healthcare service platform operators. Our flexible collaboration models create win-win outcomes for both Pomdoctor and our pharmaceutical partners by effectively integrating the strengths of each party in a cost-efficient ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK4159","POM","CAGR"],"gpt_icon":0},{"id":"2589859522","title":"Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2589859522","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589859522?lang=en_us&edition=fundamental","pubTime":"2025-12-05 08:37","pubTimestamp":1764895028,"startTime":"0","endTime":"0","summary":"Pomdoctor (POM) opened H1 2025 with revenue of CNY 192.4 million and basic EPS of CNY -1.49, while the latest trailing twelve month figures show revenue of CNY 342.6 million and EPS of CNY -3.79. The company has seen revenue move from CNY 177.0 million in H2 2023 to CNY 192.4 million in H2 2024, with net income excluding extra items shifting from CNY -71.3 million to CNY -76.6 million over the same period, setting up a story where investors are weighing top line momentum against still...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pom/pomdoctor/news/pomdoctor-pom-losses-persist-as-price-to-sales-premium-tests","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pom/pomdoctor/news/pomdoctor-pom-losses-persist-as-price-to-sales-premium-tests","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["POM"],"gpt_icon":1},{"id":"2588249350","title":"Pomdoctor H1 EPS $(1.60), Sales $24.400M","url":"https://stock-news.laohu8.com/highlight/detail?id=2588249350","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588249350?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:28","pubTimestamp":1764797332,"startTime":"0","endTime":"0","summary":"Pomdoctor (NASDAQ:POM) reported quarterly losses of $(1.60) per share.  The company reported $24.400 million in sales this quarter.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49197108/pomdoctor-h1-eps-1-60-sales-24-400m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USAW.SI","SQQQ","PSQ","USJW.SI",".IXIC","TQQQ","TSYW.SI","QID","BK4175","QLD","NVIW.SI","POM","MNQmain","NQmain"],"gpt_icon":0},{"id":"2588702487","title":"Pomdoctor Ltd. HY net loss attributable to shareholders at USD 66.7 million, down over six times","url":"https://stock-news.laohu8.com/highlight/detail?id=2588702487","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588702487?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:16","pubTimestamp":1764796576,"startTime":"0","endTime":"0","summary":"Pomdoctor Ltd. reported its unaudited financial results for the first half  of fiscal 2025. The company posted a net loss of USD 14.0 million for the period. Net loss attributable to shareholders was USD 66.7 million. Total comprehensive loss reached USD 14.0 million for the first half of 2025. Cash paid for interest expense amounted to USD 1.1 million. The figures reflect the company's ongoing efforts in market expansion and revenue diversification amid a challenging macroeconomic environment and intensified competition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via PR Newswire  on December 03, 2025, and is solely responsible for the information contai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL8T7ZNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"gpt_icon":0},{"id":"2588248710","title":"Press Release: POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2588248710","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588248710?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:15","pubTimestamp":1764796500,"startTime":"0","endTime":"0","summary":"GUANGZHOU, China, Dec. 3, 2025 /PRNewswire/ -- Pomdoctor Limited  , a leading online medical services platform for chronic diseases in China, today announced its unaudited financial results for the six months ended June 30, 2025.Mr. Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor, commented: \"The first half of fiscal year 2025 reflected our deliberate and disciplined efforts to balance business expansion with operational rigor. Despite a challenging macroeconomic environment and intensified market competition, we strived to strengthen our market coverage and penetration, while optimizing and diversifying our revenue streams through the vigorous promotion of our internet-hospital services and online sales. During the period, we continued to solidify our partner-doctor pool by offering higher service fees, and at the same time meaningfully enhanced our collaboration with pharmaceutical manufacturers to drive online sales and adapt to China's evolving healthcare landscape.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPO","POM","BK4175"],"gpt_icon":0},{"id":"2574122217","title":"PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2574122217","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574122217?lang=en_us&edition=fundamental","pubTime":"2025-10-10 17:57","pubTimestamp":1760090220,"startTime":"0","endTime":"0","summary":"The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 million. Just last month wewrote abouta Chinese company that suddenly decided to supersize its Nasdaq IPO in response to a looming new rule designed to weed out small – and often suspicious – new listings by foreign firms. But another company, internet-based healthcare providerPomDoctor Ltd., ignored those pending changes, proceeding with a listing plan that didn't seem to comply with the new rules.At $4 per ADS, the listing raised about $20 million, which would have violated the new Nasdaq rule requiring the $25 million minimum. And if the shares ultimately fall sharply, which could happen due to a valuation that looks quite aggressive, the company could also be subject to the proposed rule creating an expedited delisting process for any foreign company whose share float falls below","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/10/PomDoc-1010-900x600-1.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/10/PomDoc-1010-900x600-1.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/Opinion/25/10/48143238/pomdoctor-debuts-on-nasdaq-ahead-of-new-listing-rules","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/Opinion/25/10/48143238/pomdoctor-debuts-on-nasdaq-ahead-of-new-listing-rules","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["QLD","TSYW.SI","PSQ","POM","NQmain",".IXIC","QID","USAW.SI","MNQmain","TQQQ","NVIW.SI","SQQQ","USJW.SI"],"gpt_icon":1},{"id":"1117053116","title":"US Stock Movement | PomDoctor (POM.US) Falls Nearly 4% in After-Hours Trading Following 0.75% Gain on Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1117053116","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117053116?lang=en_us&edition=fundamental","pubTime":"2025-10-09 15:50","pubTimestamp":1759996218,"startTime":"0","endTime":"0","summary":"On Thursday, shares of PomDoctor (POM.US), a Chinese chronic disease management online platform, declined in after-hours trading. As of press time, the stock fell 3.72% to $3.88. PomDoctor went...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","ARTL","NDX","BK4007","159632","TQQQ","POM","BK1147","QQQ","USAW.SI","TSYW.SI","SQQQ","QLD","NVIW.SI","03086","QID","MNQmain","USJW.SI",".IXIC","PSQ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.7lk.com","stockEarnings":[{"period":"1week","weight":0.58},{"period":"1month","weight":0.6671},{"period":"3month","weight":-0.0616},{"period":"6month","weight":-0.901},{"period":"ytd","weight":0.3432}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":-0.003209},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.006939},{"month":3,"riseRate":0.416667,"avgChangeRate":0.000443},{"month":4,"riseRate":0.638889,"avgChangeRate":0.023936},{"month":5,"riseRate":0.611111,"avgChangeRate":0.009548},{"month":6,"riseRate":0.555556,"avgChangeRate":0.007738},{"month":7,"riseRate":0.472222,"avgChangeRate":-0.002395},{"month":8,"riseRate":0.638889,"avgChangeRate":0.009613},{"month":9,"riseRate":0.388889,"avgChangeRate":-0.006581},{"month":10,"riseRate":0.722222,"avgChangeRate":0.024007},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.013553},{"month":12,"riseRate":0.638889,"avgChangeRate":0.020925}],"exchange":"NASDAQ","name":"PomDoctor","nameEN":"PomDoctor"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PomDoctor(POM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PomDoctor(POM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PomDoctor,POM,PomDoctor股票,PomDoctor股票老虎,PomDoctor股票老虎国际,PomDoctor行情,PomDoctor股票行情,PomDoctor股价,PomDoctor股市,PomDoctor股票价格,PomDoctor股票交易,PomDoctor股票购买,PomDoctor股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PomDoctor(POM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PomDoctor(POM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}